CORRALES, NM, February 02, 2026 /24-7PressRelease/ -- Janet B. Arrowsmith, MD, has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Arrowsmith has had a distinguished career in medicine, in public health and regulatory consulting, marked by her expertise in internal medicine, epidemiology, and regulatory affairs. Since 2008, she has served as president and sole proprietor of Arrowsmith Consulting, LLC. Based in Corrales, NM, she has provided epidemiological and regulatory consulting to companies regulated by the U.S. Food and Drug Administration (FDA) as well as consulting work in the legal arena.

From 1999 to 2008, Dr. Arrowsmith served as president of Arrowsmith-Lowe Consulting, LLC, a drug, biologic and medical device consulting firm founded by her now ex-husband and which she joined in 1999. During this period, she provided her medical, regulatory and epidemiologic expertise to companies, law firms, and NIH advisory committees.

Before her consulting career, Dr. Arrowsmith practiced as an internal medical physician at Internal Medicine Associates in Ruidoso, NM. She provided comprehensive care to patients in a rural setting, furthering her commitment to accessible health care. Prior to her work in Ruidoso, Dr. Arrowsmith had spent two years as senior specialty consultant and primary care provider at the Mescalero Indian Health Service Hospital from 1996 to 1998. In this role, she delivered primary care service to the Mescalero Apache community, serving as a commissioned officer in the U.S. Public Health Service.

Dr. Arrowsmith's tenure at the FDA included several key positions. She began her career at FDA in 1984 as a medical epidemiologist assigned to the Center for Drug Evaluation and Research at FDA during her CDC fellowship in epidemiology. From 1984 to 1988, she helped analyze and assess adverse events reported in association with the use of marketed drug products as well as participate in infectious disease and other outbreak investigations, resulting in reports accepted in the peer-reviewed medical literature. Also, within that FDA Center, from 1991 t0 1993 in the Antivirals Division, she assisted in the review of Didanosine (DDI), the second drug approved for treatment of HIV/AIDS, served as human safety officer within that Division, and was author of the section of the initial DDI labeling addressing pancreatitis. From 1993 to 1995, she served as acting Office Director at the Office of Surveillance and Biometrics in the Center for Devices and Radiologic Health at FDA. In that position, she hired staff, worked with industry on refining reporting regulations, and directed outbreak investigations for adverse events related to medical devices. As a Medical Review Officer in the Center for Biologics Evaluation and Research from 1995 to 1996, she was primary author for the first patient consent form addressing human transplantation of non-human organs and tissues as well as providing regulatory oversight of biologic products such as snake antivenins. She also served on FDA's MedWatch Coordinating Committee, developing a publicly accessible adverse event reporting database.

Among other notable contributions, from 1986 to 1996, she served as a clinical instructor in Georgetown University's internal medicine department. She served as Visiting Professor of Epidemiology at an International Pharmacoepidemiology meeting in Erice Italy in 1987. She also consulted with the National Institutes of Health on several projects and has served as a guest lecturer at both Temple University and Rutgers Business School. She currently serves as a clinical assistant professor with the Community Faculty Department at the University of New Mexico School of Medicine.

Dr. Arrowsmith's educational background laid a strong foundation for her career accomplishments. She earned a Bachelor of Arts in zoology from Duke University in Durham, North Carolina, in 1971. Her early interest in medicine was influenced by her father, a prominent hematologist-oncologist, and further developed by research projects after college evaluating federal funding gaps in Louisiana's Charity Hospital system. Dr. Arrowsmith graduated with a Degree in Medicine from the Tulane University of Medicine in New Orleans in 1979 and in 1982 completed her residency in internal medicine at the University of Alabama in Birmingham. She was then selected for a fellowship in epidemiology through the Centers for Disease Control and Prevention (CDC) in 1984. Dr. Arrowsmith is board-certified in Internal Medicine and maintains her medical licensure in New Mexico.

Throughout her professional career, Dr. Arrowsmith has maintained her elected fellowship in both the American College of Physicians and the American College of Epidemiology. She has been an active member of other scientific organizations such as the American Association for the Advancement of Science, the International Society of Pharmacoepidemiology, as well as the Drug Information Association. Dr. Arrowsmith's extensive civic engagement includes her role as past president of the board of directors for New Mexico Organized Against Trafficking Humans, advocating statewide against human trafficking and providing information and education to combat human trafficking. Since 2020 she has served on the board of directors of the Trinity House Catholic Worker in Albuquerque and since 2023, has served on the board of directors of Prison Lights, Incorporated, an organization aimed at educating physicians and lawyers about the appalling lack of adequate medical care in prisons in NM and elsewhere in this country.

As a recognized expert in her field, Dr. Arrowsmith has made significant contributions to the scientific literature as serving as author or co-author for CDC textbook chapters and a chapter in the first textbook of pharmacoepidemiology, addressing FDA's role in medical product safety surveillance and response. Prior to starting medical school, she served several years as editor for the Sierra Club newsletter for Louisiana, Arkansas, and Texas. She has engaged in freelance writing projects, contributed as an author to articles in the peer-reviewed literature, presented works before various scientific groups and mentored other young scientists in their professional journeys.

Dr. Arrowsmith's contributions to HIV/AIDS research and care are among her most significant achievements. As senior medical officer for HIV at the Agency for Healthcare Policy and Research, she established an expert panel to develop guidelines for HIV/AIDS diagnosis and treatment for primary care physicians. She played a central role in and was commended for development of the AIDS Clinical Trials Information Service (ACTIS), the first publicly available data source on active clinical trials, which addressed HIV/AIDS. For 8 years, she was a volunteer primary care provider at an HIV/AIDS community clinic in Washington, D.C.

Dr. Arrowsmith's work has been recognized with numerous awards, including PHS citations for epidemiological studies on aspirin use and Reye syndrome, infant deaths associated with an unapproved product called E-Ferol, as well as for her outstanding efforts in coordination of AIDS activities at FDA. Among other accolades, she has been awarded a U.S. Department of Health and Human Services Secretary Award for issues related to the safety of home-based respiratory monitoring systems for premature infants. In 2014, she received an award from the Washington Office of Civil Rights honoring her as a "Woman of Character, Courage, and Commitment" for her work in combatting human trafficking. Dr. Arrowsmith's legacy is defined by her unwavering commitment to public health through her HIV/AIDS contributions, her advocacy for victims of human trafficking, and her continued efforts at promoting the rights of the underprivileged and persons incarcerated by state prison systems.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #